Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Bristol-Myers and J&J will study a combination of 2 of their hepatitis C drug candidates
Bristol-Myers and J&J will study a combination of 2 of their hepatitis C drug candidates
Bristol-Myers and J&J will study a combination of 2 of their hepatitis C drug candidates
Submitted by
admin
on December 2, 2011 - 12:04pm
Source:
Yahoo/AP
News Tags:
Bristol-Myers Squibb
JNJ
hepatitis C
daclatasvir
TMC435
Headline:
Bristol-Myers and J&J will study a combination of 2 of their hepatitis C drug candidates
Do Not Allow Advertisers to Use My Personal information
